Cook Medical’s EUDC Celebrates 5th Birthday
Cook Medical’s European Distribution Centre (EUDC) located in Baesweiler, Germany, is celebrating its fifth birthday this December. The EUDC is the storage and distribution centre for Cook products in Europe and the central shipping point for Cook Medical manufactured devices to all EMEA countries. The EUDC employs 85 people and handles approximately 2000 shipments per day.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161219005480/en/
The EUDC’s location in ‘The Blue Banana’ region, one of Europe’s most efficient logistics locations, continues to support Cook’s goal of getting the right product to the right patient in time.
Speaking on the eve of the fifth year celebration, Pat Burke, Director of Operations said:
“The EUDC has been integral to the growth of Cook Medical globally. The centre is the backbone to our distribution network in EMEA. Since consolidating distribution to Baesweiler the company has been able to deliver potentially life changing devices to more countries in a shorter space of time. For example, once an order is placed on our system from a hospital or clinician, the items on the order are picked, packed and processed through the DC and on a dock trailer within minutes ready for pick up by our dedicated carrier early next day for delivery. This is all thanks to the dedicated and hardworking team at EUDC.”
Uwe Henze, EUDC Manager, is also marking his five years in Cook at the event:
“I am very proud of what we have achieved for ourselves and for Cook over the last 5 years. Although our day to day work environment is busy and fast paced , the team work very hard to ensure our customers and patients get the devices they need as quickly as possible. I would like to extend my gratitude to the dedication of my colleagues and congratulate them on the role they’ve played in reaching this 5 year milestone.”
The first shipment was on the 5th December 2011. The purpose-built facility combines warehousing and shipping from multiple Cook locations in Europe. Today, the total number of inventory products held in the EUDC is approximately 750,000 units. The facility was built with energy-efficiency in mind, incorporating solar panels and advanced insulating materials. All Distribution Centre processes are paperless while air pillows replaced serrated paper in padding for shipments.
About Cook Medical
Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials, and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees, and our communities. We have 10 strategic business units addressing multiple medical specialties from vascular disease to reproductive health.
Lisa Towell, +353876356583
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
FL-GA-TELESIS11.12.2017 06:03 | pressemeddelelse
GA Telesis Launches Leveraged Finance Group with the Appointments of David Lloyd and Nolan Heske
ASTRAZENECA10.12.2017 23:47 | pressemeddelelse
AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials
NJ-CELGENE/BLUEBIRD-BIO10.12.2017 16:32 | pressemeddelelse
Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti-BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting
GA-GILEAD-SCIENCES/KITE10.12.2017 16:32 | pressemeddelelse
Kite Announces Long-Term Data From Pivotal ZUMA-1 Study of Yescarta™ (Axicabtagene Ciloleucel) in Patients With Refractory Large B-cell Lymphoma
MA-TAKEDA/SEATTLE10.12.2017 14:02 | pressemeddelelse
Takeda and Seattle Genetics to Present Positive Data from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma
ASTRAZENECA9.12.2017 19:02 | pressemeddelelse
AstraZeneca’s Calquence (acalabrutinib) Demonstrates Activity in Relapsed or Refractory Mantle Cell Lymphoma Trial
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum